Retailer & Marketplace
CVS Health vs Giant Eagle
Structured technology and market comparison · 2026
Direct Feature Comparison
CVS Health · vs · Giant EagleIntegrated US pharmacy, insurance, care delivery and retail media company.
Regional grocer combining supermarkets, loyalty, e-commerce and retail media.
Analyze all overlapping signals and tech stacks for CVS Health and Giant Eagle
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between CVS Health and Giant Eagle?
When comparing CVS Health and Giant Eagle, both platforms operate within the Retail Media Technology, Connected TV (CTV) & OTT, and Retailer & Marketplace ecosystem. CVS Health is positioned as Integrated US pharmacy, insurance, care delivery and retail media company, whereas Giant Eagle focuses on Regional grocer combining supermarkets, loyalty, e-commerce and retail media. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to CVS Health and Giant Eagle?
When evaluating CVS Health and Giant Eagle, enterprise buyers also consider other platforms in Retail Media Technology, Connected TV (CTV) & OTT, and Retailer & Marketplace. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of CVS Health and Giant Eagle compare?
CVS Health is headquartered in US (founding year unrecorded) with >5,000 employees. Giant Eagle is based in US (founded in 1931) with >5,000 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: CVS Health vs Giant Eagle
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
CVS Health
Recent Signals
- ·CNBC InvestingFinancials
Goldman recommends defensive stocks amid AI bull concerns
Goldman Sachs advises investors concerned about a potential slowdown in the AI trade to consider defensive stocks in health care and consumer staples. The bank notes that AI capital spending currently contributes about half of S&P 500 earnings growth, but expects this to diminish as spending growth slows. Rising energy prices and interest rates are clouding the economic outlook, with higher financing costs raising doubts about the durability of the AI infrastructure buildout. Goldman's screen highlights companies with high free cash flow yields and recent underperformance, such as Tyson Foods (11% FCF yield, down 17% over six months) and CVS Health (9% FCF yield, down 15% in three months). Despite these defensive recommendations, Goldman's base case still expects continued earnings growth, with a potential catch-up trade in consumer-facing stocks fueled by weaker energy prices and falling interest rates anticipated in 2027.
- Goldman Sachs recommends defensive stocks in health care and consumer staples amid AI trade concerns.
- AI capital spending contributes about half of S&P 500 earnings growth, but Goldman expects this to diminish.
- Rising energy prices and interest rates are clouding the economic outlook.
- ·SEC APIfinancials
10-Q Financial Filing Analysis for CVS Health (2026-08-05)
CVS Health Corporation reported strong financial results for the second quarter of 2026, driven by top-line growth across all major operating segments. Total revenues increased 7.3% year-over-year to $106.10 billion, up from $98.92 billion in Q2 2025. Operating income saw a substantial 97.5% increase to $4.70 billion, compared to $2.38 billion in the prior-year period, primarily supported by core operational improvements and the absence of $833 million in legacy litigation charges incurred in Q2 2025. Net income attributable to CVS Health rose significantly to $2.98 billion ($2.31 diluted EPS) from $1.02 billion ($0.80 diluted EPS). Performance in the Health Care Benefits segment reflected improved medical loss dynamics, with the Medical Benefit Ratio (MBR) declining to 87.4% from 89.9% in Q2 2025, driven by improved underlying Government business performance and the absence of prior-year premium deficiency reserves. Growth was supported by the Health Services segment, where revenues climbed 11.5% to $51.80 billion, and Pharmacy & Consumer Wellness, which posted a 2.9% increase in pharmacy same-store sales aided by Rite Aid file acquisitions. In regulatory matters, CVS reached a proposed settlement with the FTC to resolve outstanding PBM and pharmacy inquiries.
- Q2 2026 consolidated total revenues reached $106.10 billion, an increase of 7.3% year-over-year, with operating income increasing 97.5% to $4.70 billion.
- Health Care Benefits Medical Benefit Ratio (MBR) improved by 250 bps year-over-year to 87.4%, while total medical membership stood at 26.02 million as of June 30, 2026.
- Operating cash flow for the first six months of 2026 increased 64.2% year-over-year to $10.59 billion, supporting $3.29 billion in long-term debt repayments.
- ·Pixability
Pixability Appoints Norm de Greve, Former General Motors CMO and Chairman of the MMA, to its Advisory Board
Norm de Greve, former CMO of General Motors and CVS Health and Chairman of the MMA, has joined the advisory board of Pixability, a leading AI-driven technology company that helps brands maximize YouTube advertising. In an interview with AdExchanger, de Greve highlights common mistakes brands make with YouTube marketing, emphasizing the need for an integrated strategy across paid, owned, and creator channels, which most brands lack. He also notes YouTube's growing importance as a top source for AI search and advocates for a holistic approach to content and creator management. De Greve critiques current AI use in marketing, urging brands to redesign workflows around AI rather than optimize old processes. Pixability's AI-driven approach aims to help marketers analyze organic content, amplify successful strategies, and allocate budgets more effectively across YouTube's ecosystem.
- Norm de Greve, former CMO of General Motors and CVS Health and Chairman of the MMA, joined Pixability's advisory board.
- Pixability is a YouTube-focused AI company that helps brands maximize paid and owned media and leverage creators.
- De Greve advises brands to integrate paid, owned, and creator YouTube strategies.
Giant Eagle
Recent Signals
- ·Modern RetailRetail Media
Grocers Detail Agentic AI Shopping Assistants at Groceryshop
At Groceryshop 2026, executives from Kroger, Giant Eagle, and DoorDash discussed their strategies for deploying agentic AI shopping assistants. Kroger's chief digital officer, Yael Cosset, emphasized reducing friction between inspiration and purchase, with the retailer's AI assistant generating baskets from photos, recipes, or dietary constraints. Giant Eagle's Shweta Prabhu and Heather Feather highlighted using AI to convert single-channel shoppers into omnichannel ones, citing 30% higher lifetime value, and noted they integrated e-commerce operations with marketing and merchandising teams last year. DoorDash co-founder Andy Fang stated that users prefer practical tools like 'reorder my usuals' over chat interfaces, and is building native features for real-time order modification. The integrations come amid Kroger's planned acquisition of Giant Eagle, expected to close in 2027. Retailers face pressure to deploy AI quickly, but Cosset stressed the importance of speed with precision.
- Kroger launched an AI shopping assistant that creates baskets from photos, recipes, or dietary context.
- Giant Eagle reported omnichannel shoppers have 30% higher lifetime value than single-channel shoppers.
- Giant Eagle combined its e-commerce operations team with marketing and merchandising teams last year.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners CVS Health and Giant Eagle share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks